Stay updated on Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page.

Latest updates to the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedVersion history now includes a new Revision: v3.6.5 entry, replacing the previous Revision: v3.6.4 in the study record history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study history now shows a new revision entry v3.6.4. The prior revision v3.6.3 is removed from the history.SummaryDifference0.1%

- Check45 days agoChange DetectedThe revision history now shows a new version label, updating from v3.6.2 to v3.6.3, indicating an additional revision entry in the page history.SummaryDifference0.1%

- Check53 days agoChange DetectedThe Record History page updated the revision from v3.6.0 to v3.6.2, signaling a newer version of the page history. This reflects an update to the page's metadata rather than substantive changes to study data.SummaryDifference0.1%

- Check67 days agoChange DetectedRecruitment status was updated to No longer looking for participants, with the record returned on 2026-06-11 and a pending Quality Control review. The history also adds Outcome Measures sections and updates the revision version to v3.6.0, replacing v3.5.5.SummaryDifference1%

- Check74 days agoChange DetectedA new revision entry (v3.5.5) was added to the study history, becoming the latest version, while the previous revision (v3.5.4) was removed from the current history listing.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy in Myeloma with Kidney Failure Clinical Trial page.